Quantcast

Latest Molecular Insight Pharmaceuticals Inc. Stories

2014-03-26 16:25:57

LONDON, March 26, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Global Radiopharmaceutical Market 2012-2016 TechNavio's analysts forecast the Global Radio Pharmaceutical market to grow at a CAGR of 18.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Radio Pharmaceutical market has also been witnessing the increasing demand for radiopharmaceuticals....

2009-09-10 08:54:00

NEW YORK, Sept. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. US and European Radiopharmaceuticals Market http://www.reportlinker.com/p0109914/US-and-European-Radiopharmaceuticals-Market.html This report analyzes the US and the European markets for Radiopharmaceuticals in Millions of US$. The major product segments analyzed are Diagnostic Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals. Annual forecasts are...

2008-11-13 09:00:37

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today the financial results for the third quarter and nine months ended September 30, 2008. In a conference call scheduled for 10:00 a.m., Eastern Daylight Time, the Company will also discuss the positive Zemiva Phase 2b clinical trial data recently presented at the American Heart Association Annual Meeting on November 9th and provide an update on program developments. Operating Highlights: Zemiva Reported...

2008-11-05 09:00:08

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that John W. Babich, Ph.D., Interim Chairman and Chief Executive Officer of Molecular Insight Pharmaceuticals, will present at the upcoming Rodman and Renshaw 10th Annual Healthcare Conference on Wednesday, November 12, 2008. During his presentation, Dr. Babich will provide an overview of the Company and its pipeline of molecular imaging radiopharmaceutical and targeted molecular radiotherapeutic candidates. The...

2008-10-30 09:00:13

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that it will release its third quarter 2008 financial results before the opening of the Market and will hold a conference call on Thursday, November 13, 2008 at 10:00 a.m. Eastern Time. During the call, senior management of Molecular Insight will review the Company's financial results and provide an update on its clinical development programs. Conference Call Details To access the live call on November 13, 2008...

2008-09-25 17:46:24

The Board of Directors of Molecular Insight Pharmaceuticals, Inc. (the "Company") (NASDAQ: MIPI) announced today that John Babich, President and Chief Scientific Officer of the Company, will replace David S. Barlow as the Company's interim CEO and Chairman of the Board, effective immediately. Mr. Barlow will continue to serve out his term as a member of the Company's Board of Directors. The Company had begun a search to identify a permanent CEO. The Company's Board said: "The Board...

2008-09-22 09:00:18

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) today announced that it has expanded its Board of Directors with the addition of four industry leaders in healthcare. The new, independent directors joining the Board include healthcare Industry veterans: David R. Epstein, President and CEO of Novartis Oncology; Dr. Yvonne Greenstreet, Senior Vice President and Chief of Strategy, R&D, GlaxoSmithKline; Joseph M. Limber, President and Chief Executive Officer of Prometheus Laboratories,...

2008-09-22 09:00:18

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that David S. Barlow, Chairman and Chief Executive Officer of Molecular Insight Pharmaceuticals, will present at the upcoming UBS Global Life Sciences Conference on Wednesday, September 24, 2008. During his presentation, Mr. Barlow will provide an overview of the Company and its pipeline of molecular imaging radiopharmaceutical and targeted molecular radiotherapeutic candidates. The presentation will take place at 12:00...

2008-08-27 09:00:31

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that David S. Barlow, Chairman and Chief Executive Officer of Molecular Insight Pharmaceuticals, will present at the upcoming Thomson Reuters and BioCentury NewsMakers in the Biotech Industry Conference on Thursday, September 4, 2008. During his presentation, Mr. Barlow will provide an overview of the Company and its pipeline of molecular imaging radiopharmaceuticals and targeted molecular radiotherapeutic candidates. The...

2008-08-13 09:01:15

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today financial results for the second quarter and six months ended June 30, 2008 and provided guidance for clinical milestones through the first half of 2009. Second Quarter 2008 Highlights Molecular Insight successfully completed several milestones during the second quarter: Zemiva -- Completed enrollment of the Zemiva planned pivotal Phase 2 clinical trial for the detection of cardiac ischemia in the...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related